FDMD.F Stock Overview
4DMedical Limited operates as a medical technology company in Australia and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
4DMedical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.45 |
| 52 Week High | AU$0.60 |
| 52 Week Low | AU$0.40 |
| Beta | 1.29 |
| 1 Month Change | 9.93% |
| 3 Month Change | -1.07% |
| 1 Year Change | n/a |
| 3 Year Change | -65.75% |
| 5 Year Change | n/a |
| Change since IPO | -72.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| FDMD.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 2.0% |
| 1Y | n/a | -10.4% | 22.3% |
Return vs Industry: Insufficient data to determine how FDMD.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how FDMD.F performed against the US Market.
Price Volatility
| FDMD.F volatility | |
|---|---|
| FDMD.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FDMD.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FDMD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 131 | Andreas Fouras | 4dmedical.com |
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator.
4DMedical Limited Fundamentals Summary
| FDMD.F fundamental statistics | |
|---|---|
| Market cap | US$154.72m |
| Earnings (TTM) | -US$20.15m |
| Revenue (TTM) | US$669.90k |
231.0x
P/S Ratio-7.7x
P/E RatioIs FDMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FDMD.F income statement (TTM) | |
|---|---|
| Revenue | AU$1.03m |
| Cost of Revenue | AU$51.29k |
| Gross Profit | AU$973.93k |
| Other Expenses | AU$31.81m |
| Earnings | -AU$30.83m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.079 |
| Gross Margin | 95.00% |
| Net Profit Margin | -3,007.65% |
| Debt/Equity Ratio | 0% |
How did FDMD.F perform over the long term?
See historical performance and comparison